Dr. Junning Zhao is a Research Professor with an M.D. and postdoctoral training in pharmaceutical sciences. He serves as Vice Chair of the 12th Chinese Pharmacopoeia Commission. His research focuses on traditional Chinese medicine regulatory science, TCM pharmacology and new drug development, safety evaluation, and TCM nanoscience. Dr. Zhao has made important contributions to the establishment and translational application of a regulatory science system for traditional Chinese medicine. He has served as editor-in-chief of more than 30 academic monographs, including Regulatory Science of Traditional Chinese Medicine, Translational Chinese Medicine, and Toxicity Theory and Safety Evaluation of Traditional Chinese Medicine. He has published over 360 academic papers in journals such as Science China Life Sciences, Chinese Science Bulletin, Signal Transduction and Targeted Therapy, Food Chemistry, and Phytomedicine. His achievements have received one Second Prize of the National Science and Technology Progress Award and six First Prizes of provincial or ministerial awards. His work on TCM regulatory science was selected as one of the Top Ten Academic Advances in Traditional Chinese Medicine in 2023. He has also been recognized as a Tianfu Distinguished Scientist of Sichuan Province, an Academic and Technical Leader of Sichuan Province, a recipient of the First Sichuan Outstanding Talent Award, and an expert receiving the Special Government Allowance of the State Council.